Instillation of Gemcitabine in Patients With Superficial Bladder Cancer

Clinical trial NCT00191477 · TERMINATED

Trial details

NCT number: NCT00191477
Sponsor: Eli Lilly and Company
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Bladder Neoplasms

Start date: 2004-01-01
Primary completion: 2008-03-01
Enrollment: 355

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.